NCT04221711

Brief Summary

With this prospective, randomized, controlled trial the investigators want to investigate effects of a prolonged repetitive Peripheral Magnetic Stimulation (rPMS) intervention on Achilles tendinopathy and compare it to a well established intervention. This may provide clinicians with a new, non-pharmacological, non-invasive, near painless approach to treat tendinopathy. Although promising results with comparable devices exist, a direct and valid conclusion on the overall clinical performance of the investigational device cannot be drawn. This is mainly due to different treatment protocols used in the literature and due to the lack of insight in the technical documentation of comparable devices. Further, the applied magnetic fields vary in their amplitude, frequency, waveform and/or stimulation durations. Therefore, the main goal of this clinical investigation is the collection of clinical data on the clinical performance of the investigational device. This clinical data will subsequently serve as a main source for the clinical evaluation of the medical device.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 2, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

January 9, 2020

Completed
8 months until next milestone

Study Start

First participant enrolled

September 4, 2020

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 4, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 4, 2021

Completed
Last Updated

September 7, 2020

Status Verified

September 1, 2020

Enrollment Period

1 year

First QC Date

January 2, 2020

Last Update Submit

September 4, 2020

Conditions

Keywords

TendinopathyAchillesRepetitive Magnetic Stimulation

Outcome Measures

Primary Outcomes (3)

  • Change of the experience of pain and functionality with the Victorian Institute of Sports Assessment questionnaire (VISA-A)

    Change of the experience of pain and functionality as assessed by the Victorian Institute of Sports Assessment questionnaire (VISA-A). The VISA-A questionnaire is a validated questionnaire with good test-retest, intra-rater and inter-rater reliability and is especially designed for patients with Achilles tendinopathy. The maximum score that can be achieved on the question is 100, and would be the score of person who is completely asymptomatic. A lower score indicates more symptoms and greater limitation of physical activity.

    "Week 0", "Week 12"

  • Change of the experience of pain at exertion as assessed by the Visual Analogue Scale (VAS)

    Psychometric response scale with continuous aspect (Visual Analogue Scale (VAS)). 0 means low ("no pain"), 100 means high (Pain as bad as could possibly be).

    "Week 4", "Week 12"

  • Percentage of participants with an anticipated adverse event of special interest

    Percentage of participants with an anticipated adverse event of special interest (muscle twitching, local warming and initial pain excitement). The occurrence of the expected side-effects is not definitely clear based on literature and pre-clinical investigations.

    "Week 4"

Secondary Outcomes (30)

  • Change of the experience of pain and functionality with the Victorian Institute of Sports Assessment questionnaire (VISA-A)

    "Week 0", "Week 2"

  • Change of the experience of pain and functionality with the Victorian Institute of Sports Assessment questionnaire (VISA-A)

    "Week 0", "Week 4"

  • Change of the experience of pain and functionality with the Victorian Institute of Sports Assessment questionnaire (VISA-A)

    "Week 0", "Week 6"

  • Change of the experience of pain and functionality with the Victorian Institute of Sports Assessment questionnaire (VISA-A)

    "Week 0", "Week 8"

  • Change of the experience of pain and functionality with the Victorian Institute of Sports Assessment questionnaire (VISA-A)

    "Week 0", "Week 24"

  • +25 more secondary outcomes

Study Arms (2)

Repetitive pulsed magnetic stimulation

EXPERIMENTAL

Patients randomized in this group will receive rPMS (80 milliTesla ; 2 Hertz; OMNITRON® promed; Healthfactories Holding GmbH) three times a week for a total of 12 weeks. Thereby they will be lying in a prone position or sitting for 20 minutes with the magnet coil positioned over the mid-portion of the affected Achilles tendon (manufactures instruction).

Device: Repetitive pulsed magnetic stimulation

Eccentric Calf Muscle Training for Achilles Tendinopathy

ACTIVE COMPARATOR

Two types of eccentric exercises will be used. The calf muscle will be eccentrically loaded both with the knee straight and with the knee bent. Each of the two exercises will include an increasing number of repetitions (1. Week, 2-3 weeks, 4-12 weeks) done in 3 sets (e.g. 3x15, 3x20, 3x30 repetitions). The patients will be informed that muscle soreness during the first 1 to 2 weeks of training was to be expected. Patients will receive a visual exercise protocol.

Procedure: Eccentric Calf Muscle Training for Achilles Tendinopathy

Interventions

OMNITRON ProMed is a rPMS (repetitive peripheral magnetic stimulation) device used for deep stimulation of muscles and/or neurones (outside the brain). The energy is delivered by way of a special round treatment coil, whose cover material is tested for biocompatibility. The OMNITRON ProMed device produces a high-energy impulse field and stimulates tissue, in particular soft tissue, muscles and neurons, by means of repetitive peripheral magnetic stimulation (rPMS). Short, extremely strong magnetic fields in the microsecond range are emitted non-invasively. OMNITRON ProMed works with short-term energy emission at a peak power of up to 60 million watts and a magnetic field strength of up to 100 milliTesla. The intensity of treatment can be set between 20 and 100 %. The device automatically adjusts the magnetic field strength and the frequency of the pulses emitted depending on the intensity selected. For comfortable transport and application the product is compact and portable.

Repetitive pulsed magnetic stimulation

Patients will be asked to stand with their full body weight on the injured leg. From an upright body position and standing with all body weight on the forefoot and the ankle joint in plantar flexion, the calf muscle is then loaded by having the patient slowly lower the heel beneath the forefoot. The calf muscle will only be loaded eccentrically, not concentric. Instead, the non-injured leg is used to get back to the start position. The first set of this exercise is performed in an upright position, followed by a second set with the knee bent to 45°. This regimen is performed 2x per day. The patients are told to go ahead with the exercise even if they experienced pain. However, they are told to stop if the pain becomes disabling.

Eccentric Calf Muscle Training for Achilles Tendinopathy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Men and non-pregnant women aged 18-60 years
  • Patients suffering from a gradually evolving painful condition in the Achilles tendon located at the midportion for at least 12 weeks (Diagnosis based on clinical examination showing a painful thickening of the Achilles tendon located at a level of 2 to 6cm above the tendon insertion, and confirmed by ultrasonography: local thickening of the tendon, irregular tendon structure with hypoechoic areas and irregular fiber orientation).
  • VISA-A score less than 65 at baseline.
  • Be informed of the nature of the study and provide written informed consent.

You may not qualify if:

  • Clinical suspicion of insertional disorders (pain at the site of the insertion of the Achilles tendon on the calcaneum)
  • Clinical suspicion of an Achilles tendon rupture.
  • Suspicion of internal disorders: spondylarthropathy, gout, hyperlipidemia, Rheumatoid Arthritis and sarcoidosis.
  • Severe foot deformity
  • Condition that prevents the patients from executing an active exercise program
  • Pregnant or lactating females
  • History of treatment with corticosteroids, estrogens, long term quinolone antibiotics, and cholesterol drugs
  • Persons with electronic implants (e.g. pacemaker, cochlear implants, drug pump, deep brain stimulator, etc.)
  • Patients with organ transplants
  • Patients with closed, circular metal implants (e.g. subdermal implants, etc.)
  • Epilepsy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gesundheitszentrum Woergl

Wörgl, Tyrol, 6300, Austria

RECRUITING

MeSH Terms

Conditions

Tendinopathy

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesTendon InjuriesWounds and Injuries

Central Study Contacts

Andreas Traweger, Prof.Dr.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Since blinding is not possible for patients, only the statistician will be blinded with respect to the treatment group.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The study design was chosen to be a randomized, controlled trial.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 2, 2020

First Posted

January 9, 2020

Study Start

September 4, 2020

Primary Completion

September 4, 2021

Study Completion

September 4, 2021

Last Updated

September 7, 2020

Record last verified: 2020-09

Data Sharing

IPD Sharing
Will not share

Locations